InsidersTradesSigma
Track the 나이벡 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 나이벡 has recorded 1 reports. Market capitalisation: €177.3bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 나이벡. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
나이벡 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for disease treatment.